Jury Awards Plaintiff $68M In Bard Mesh Case
Executive Summary
CR Bard has lost the first transvaginal mesh case to be tried in New Jersey, but there are another 150 to go in the state. A Bergen County jury awarded $33m in compensatory damages and $35m in punitive damages to a woman who says she's experienced chronic pain and other complications since receiving two of the company's transvaginal mesh products in 2009.
You may also be interested in...
FDA Looks To Lead World In Post-Market Device Surveillance With Safety Plan, Investments
US FDA Nov. 20 announced plans for a broad series of updates to its Medical Device Safety Action Plan for the next several months, with the goal that FDA "is consistently first among the world’s regulatory agencies to identify and act upon safety signals related to medical devices.
BD, CR Bard Merger To Create Vascular Access Device Giant
Becton Dickinson has reached a definitive agreement to acquire CR Bard for $24bn. BD says Bard's product portfolio gives it a strong presence in fast-growing clinical areas and more reach outside the US while Bard expects to reach more customers by building on BD's leadership in medication management and infection prevention.
Bard, J&J Settle Mesh Cases
CR Bard has settled 150 pelvic mesh claims against the company in West Virginia, while Ethicon paid $5 million to resolve one in New Jersey. An industry observer believes this is part of a trend.